Purevax FeLV
Introduction

Company name: Merial Animal Health Ltd
Address: PO Box 327
Sandringham House
Harlow Business Park
Harlow
Essex CM19 5TG
Telephone: 01279 775858
Fax: 01279 775888
Email: ukenquiry@merial.com
Website: www.merial.com
Presentation
One vial of suspension for injection containing ≥ 107.2 FeLV recombinant Canarypox virus (vCP97) CCID 50 .
Uses
Active immunisation of cats aged 8 weeks and older against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease. Onset of immunity has been demonstrated 2 weeks after primary vaccination course.
The duration of immunity is one year after the last vaccination.
Dosage and administration
1 ml by subcutaneous injection according to the following schedule:
Primary vaccination: First injection: from 8 weeks of age.
Second injection: 3 to 5 weeks later.
Revaccination: Annual.
Contra-indications, warnings, etc
For animal treatment only.
Do not use in pregnant animals. Use is not recommended during lactation.
Undesirable effects
In exceptional circumstances a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.
A temporary, small (< 2 cm) nodule may appear at the site of injection that regresses within 1 to 4 weeks. Transient lethargy and hyperthermia may occur lasting 1 day, or exceptionally 2 days.
Special precautions for use
Vaccinate only healthy animals.
It is recommended that a test for FeLV antigenaemia be carried out prior to vaccination. Vaccination of FeLV positive cats is of no benefit.
Interaction with other veterinary medicinal products and other forms of interaction
Safety and efficacy data are available which demonstrate that this vaccine can be mixed with Merial PUREVAX non-adjuvanted vaccines for cats (various combinations of feline viral rhinotracheitis, calicivirosis, panleukopenia and chlamydiosis components) and/or administered the same day but not mixed with Merial adjuvanted vaccine against rabies (RABISIN). Do not mix with any other vaccines or immunological products.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Pharmaceutical precautions
Keep out of reach and sight of children.
Store and transport at 2°C – 8°C (in a refrigerator), protected from light. Do not freeze. Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant or by appropriate channels approved for use by the competent authorities.
Use immediately after broaching.
Legal category
POM-V
Packaging Quantities
1 dose bottle of suspension:
Box of 10 × 1 bottles.
Further information
None.
Marketing authorisation number
EU/2/00/019/005.